Krieger Scientific's Joseph Morwald explains how siloed departments, disconnected systems, and a lack of cross-functional accountability are creating the structural compliance gaps that FDA warning letters keep exposing.
Joseph Morwald
Advertisement
Joseph Morwald is founder and CEO of Krieger Scientific.
Articles by Joseph Morwald
Krieger Scientific's Joseph Morwald on why over-reliance on AI and under-reliance on human expertise is driving the surge in FDA warning letters.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
3
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
5